These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 6857302

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of erythromycin on theophylline pharmacokinetics at steady state.
    Maddux MS, Leeds NH, Organek HW, Hasegawa GR, Bauman JL.
    Chest; 1982 May; 81(5):563-5. PubMed ID: 7042226
    [Abstract] [Full Text] [Related]

  • 5. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR, Kinney CD, McDevitt DG.
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictability and intraindividual variability of serum theophylline concentrations in patients with obstructive lung disease: 12-h versus 24-h dosing.
    Schmidlin O, Vozeh S, Keller B, Perruchoud A, Follath F.
    Eur J Clin Pharmacol; 1990 Nov; 39(3):253-6. PubMed ID: 2257861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G.
    Fortschr Med; 1984 Nov 22; 102(43):1120-2. PubMed ID: 6510864
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis.
    Reisz G, Pingleton SK, Melethil S, Ryan PB.
    Am Rev Respir Dis; 1983 May 22; 127(5):581-4. PubMed ID: 6846940
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intersubject variability in plasma theophylline levels after oral and intravenous administration in Jordanian patients with chronic obstructive pulmonary disease.
    Samara N, Sliman N, Sai'd S, Awidi A, Al-Turk W, Othman S, Khalaf R, Shaheen O.
    Ther Drug Monit; 1988 May 22; 10(2):144-6. PubMed ID: 3381229
    [Abstract] [Full Text] [Related]

  • 19. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR, Kinney CD, McDevitt DG.
    Br J Clin Pharmacol; 1982 Apr 22; 13(4):569-71. PubMed ID: 7066172
    [No Abstract] [Full Text] [Related]

  • 20. Effect of erythromycin on theophylline clearance in asthmatic children.
    LaForce CF, Miller MF, Chai H.
    J Pediatr; 1981 Jul 22; 99(1):153-6. PubMed ID: 7252653
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.